
Sign up to save your podcasts
Or


Send us Fan Mail
Welcome to the third and final episode in our series on the potential of psilocybin-assisted therapy to relieve the existential distress of, and help us live as well as possible with, metastatic breast cancer.
In this episode, we speak with two women taking action to increase legal access to psilocybin-assisted therapy in the United States. The first is a patient living with MBC who, along with her doctor, has brought a lawsuit against the Drug Enforcement Agency which is denying her access to psilocybin in the palliative care setting and under existing Right to Try laws for promising investigational medications for the terminally ill. The patient petitioner, Erinn Baldeschwiler, tells us why she joined the lawsuit, what she hopes to gain from psilocybin-assisted therapy, and what it’s been like to deal with all the legal proceedings on top of a progressing MBC diagnosis.
Our second interview in this episode is with the attorney who is leading the legal case to open access to psilocybin under Right to Try legislation, Kathryn Tucker of the Emerge Law Group. Kathryn explains why psilocybin should be immediately available to patients suffering from distress, anxiety, and depression under FDA rules and state and federal Right to Try laws. But the DEA is continuing to block access and hold psilocybin on Schedule 1 of the Controlled Substance Act.
It’s confusing, but we explain it all here. Lastly, see the episode notes for a current petition to the DEA to step out of the way and grant access to psilocybin to anyone with a terminal illness.
This series has been led by our incredible series producer, Dr. Paula Jayne with expert assistance from co-host Lynda Weatherby (new to the podcast this season!), and senior producer and host Lisa Laudico.
Thanks for listening!
More info is available in our episode notes for this series on our website: www.ourmbclife.org
Got something to share? Feedback?
Email:
Send us a voice recording via email or through speakpipe on our website.
Follow us on Facebook, Instagram, and Twitter @ourmbclife
We’re so happy you joined us! If this conversation resonated with you please share it with someone who might need it. Don't forget to like and subscribe here to follow us on your favorite podcast platform so you never miss an episode. You can find more episodes, resources and ways to get involved on our website Our MBC Life. Have a topic you’d like us to cover? Email us at [email protected]. And don’t forget to follow us on our socials @ourmbclife.
Remember you are not alone.
By SHARE Cancer Support5
5858 ratings
Send us Fan Mail
Welcome to the third and final episode in our series on the potential of psilocybin-assisted therapy to relieve the existential distress of, and help us live as well as possible with, metastatic breast cancer.
In this episode, we speak with two women taking action to increase legal access to psilocybin-assisted therapy in the United States. The first is a patient living with MBC who, along with her doctor, has brought a lawsuit against the Drug Enforcement Agency which is denying her access to psilocybin in the palliative care setting and under existing Right to Try laws for promising investigational medications for the terminally ill. The patient petitioner, Erinn Baldeschwiler, tells us why she joined the lawsuit, what she hopes to gain from psilocybin-assisted therapy, and what it’s been like to deal with all the legal proceedings on top of a progressing MBC diagnosis.
Our second interview in this episode is with the attorney who is leading the legal case to open access to psilocybin under Right to Try legislation, Kathryn Tucker of the Emerge Law Group. Kathryn explains why psilocybin should be immediately available to patients suffering from distress, anxiety, and depression under FDA rules and state and federal Right to Try laws. But the DEA is continuing to block access and hold psilocybin on Schedule 1 of the Controlled Substance Act.
It’s confusing, but we explain it all here. Lastly, see the episode notes for a current petition to the DEA to step out of the way and grant access to psilocybin to anyone with a terminal illness.
This series has been led by our incredible series producer, Dr. Paula Jayne with expert assistance from co-host Lynda Weatherby (new to the podcast this season!), and senior producer and host Lisa Laudico.
Thanks for listening!
More info is available in our episode notes for this series on our website: www.ourmbclife.org
Got something to share? Feedback?
Email:
Send us a voice recording via email or through speakpipe on our website.
Follow us on Facebook, Instagram, and Twitter @ourmbclife
We’re so happy you joined us! If this conversation resonated with you please share it with someone who might need it. Don't forget to like and subscribe here to follow us on your favorite podcast platform so you never miss an episode. You can find more episodes, resources and ways to get involved on our website Our MBC Life. Have a topic you’d like us to cover? Email us at [email protected]. And don’t forget to follow us on our socials @ourmbclife.
Remember you are not alone.

38,876 Listeners

9,645 Listeners

67 Listeners

112,191 Listeners

56,577 Listeners

12,649 Listeners

10,459 Listeners

3,200 Listeners